| Betterchem |

|
|
|
| FDA approval activities
for this prescription drug:
Lotrel (amlodipine and benazepril HCl) 2.5/, 5/, and 5/, Novartis 20-364/S-016 6/20/02 6/24/02 11/18/02 11/22/02 Lotrel (amlodipine and benazepril HCl) Novartis 20-364/S-014 Norvasc (amlodipine besylate) 2.5, 5, & , Pfizer 19-787/S032 5/24/02 6/3/02 Norvasc (amlodipine besylate) 2.5, 5, & , Pfizer 19-787/S031 8/20/03 8/28/03 Norvasc (amlodipine besylate) 2.5, 5, & , Pfizer 19-787/S022 12/15/99 6/22/01 Norvasc (amlodipine besylate) Pfizer 19-787/S021 2/1/00 6/6/01 Norvasc (amlodipine besylate) 2.5, 5, & , Pfizer 19-787/S019 9/7/99 8/6/03 Norvasc (amlodipine besylate) 2.5, 5, & , Pfizer 19-787/S018 6/4/99 6/22/01 Norvasc (amlodipine besylate) Pfizer 19-787/S017 & S020 7/12/00 7/14/00 6/4/01 Norvasc Indications: Supplement provided for extensive revisions of the PRECAUTIONS: Drug Interactions subsection Amvaz (amlodipine maleate) Dr. Reddy's Norvasc (amlodipine besylate) Pfizer Inc. |
© 2009 Betterchem.com
|